[A new highly effective therapy of indolent non-Hodgkin lymphomas with bendamustin]

Onkologie. 2003 Feb;26(1):92-3. doi: 10.1159/000069873.
[Article in German]
No abstract available

Publication types

  • Congress

MeSH terms

  • Animals
  • Austria
  • Bendamustine Hydrochloride
  • Germany
  • Humans
  • Lymphoma, Non-Hodgkin / drug therapy*
  • Lymphoma, Non-Hodgkin / mortality
  • Nitrogen Mustard Compounds / adverse effects
  • Nitrogen Mustard Compounds / therapeutic use*
  • Survival Rate
  • Treatment Outcome

Substances

  • Nitrogen Mustard Compounds
  • Bendamustine Hydrochloride